Other safety alerts
|
| |
| Canada: Three unauthorized eye solutions seized from a Glorious Cosmetics store in Edmonton, Alberta, may pose serious health risks |
| |
Health Canada is advising consumers that it has seized three unauthorized eye health products from a Glorious Cosmetics store in Edmonton, Alberta (10706, 82 Avenue NW) because they may pose serious health risks. According to the product labels, these products contain prescription drugs. Prescription drugs should be taken only under the advice and supervision of a healthcare professional because they are used to treat specific diseases and may cause serious side effects. The affected products are:
- Digi Eye (Eye drops): Labelled (in Japanese) to contain neostigmine methylsulfate
- Kobayashi Aibon/Eyebon Eyewash (Eyewash): Labelled (in Japanese) to contain aminocaproic acid
- Sante FX Neo (Eye drops): Labelled (in English) to contain neostigmine methylsulfate and aminocaproic acid
Unauthorized health products have not been approved by Health Canada, which means that they have not been assessed for safety, effectiveness and quality and may pose serious health risks. They may contain ingredients, additives or contaminated ingredients not listed on the label. In addition, they may lack the active ingredients Canadians would expect them to contain to help maintain and improve their health or they may contain ingredients that could interact with other medications and foods. For all of these reasons, unauthorized health products could cause serious health effects.
Some of the unauthorized health products are packaged and labelled in Japanese characters. As a result, information about ingredients, usage, dosage and side effects may not be understood by all consumers.
Please refer to the following website in Health Canada for details:
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/../70547a-eng.php
In Hong Kong, the above products are not registered pharmaceutical products. Related news was previously issued by Health Canada, and was posted on the Drug Office website on 29 Aug 2017, 16 Feb 2019 and 16 Apr 2019.
Ends/Thursday, Jul 25, 2019
Issued at HKT 16:00
|
| |
|
